|
[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. Clinical Trials
2 actively recruiting trials across 1 location
▼ -1 trial since August 2026
Also known as: [177Lu]Lu DOTA-ABM-5G, [68Ga]Ga DOTA-5G, [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G theranostic pair
Pipeline
Phase 1: 2
Top Sponsors
- University of California, Davis2
Indications
- Cancer2
- Metastatic Nonsmall Cell Lung Cancer1
- Metastatic Cancer1
- Lung Cancer1
Sacramento, California2 trials
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
The University of California Davis Comprehensive Cancer Center
Phase 1
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
The University of California Davis Comprehensive Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.